Novel phenylalkyl diamine and amide analogs

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 295/108 (2006.01) C07D 207/04 (2006.01) C07D 207/404 (2006.01) C07D 211/06 (2006.01) C07D 211/14 (2006.01) C07D 211/22 (2006.01) C07D 211/32 (2006.01) C07D 217/04 (2006.01) C07D 223/02 (2006.01) C07D 241/04 (2006.01) C07D 295/13 (2006.01) C07D 409/12 (2006.01)

Patent

CA 2450271

The present invention relates to novel 1,2- or 1,3-diamine and amide compounds and pharmaceutically useful salts thereof and methods for treating central nervous system diseases. The present 1,2- or 1,3-diamine and amide compounds have high binding affinity to the sigma receptor.

La présente invention concerne de nouveaux composés 1,2- ou 1,3-diamine et amide ainsi que leurs sels pharmaceutiquement acceptables, et des méthodes de traitement des maladies du système nerveux central. Les composés 1,2- ou 1,3-diamine et amide présentent une forte affinité de liaison au récepteur sigma.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel phenylalkyl diamine and amide analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel phenylalkyl diamine and amide analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel phenylalkyl diamine and amide analogs will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1365643

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.